Zürcher Nachrichten - Who should get paid for nature's sequenced genes?

EUR -
AED 4.309185
AFN 77.664833
ALL 96.578153
AMD 447.171387
ANG 2.100795
AOA 1075.974916
ARS 1700.476811
AUD 1.767714
AWG 2.11499
AZN 1.993018
BAM 1.957417
BBD 2.36071
BDT 143.349055
BGN 1.95623
BHD 0.4424
BIF 3465.69311
BMD 1.173365
BND 1.515258
BOB 8.099727
BRL 6.513937
BSD 1.172048
BTN 105.019984
BWP 16.486341
BYN 3.444788
BYR 22997.944348
BZD 2.357308
CAD 1.616486
CDF 3002.053142
CHF 0.931885
CLF 0.027239
CLP 1068.571028
CNY 8.261601
CNH 8.251715
COP 4494.45541
CRC 585.383681
CUC 1.173365
CUP 31.094159
CVE 110.356654
CZK 24.322262
DJF 208.718899
DKK 7.469058
DOP 73.420665
DZD 152.282774
EGP 55.701142
ERN 17.600468
ETB 182.087276
FJD 2.683896
FKP 0.880157
GBP 0.874526
GEL 3.150516
GGP 0.880157
GHS 13.462181
GIP 0.880157
GMD 85.655547
GNF 10245.552838
GTQ 8.981459
GYD 245.223664
HKD 9.127767
HNL 30.878119
HRK 7.532879
HTG 153.677633
HUF 386.567869
IDR 19695.509941
ILS 3.76599
IMP 0.880157
INR 105.136335
IQD 1535.468701
IRR 49398.645621
ISK 147.210343
JEP 0.880157
JMD 187.544961
JOD 0.831933
JPY 184.814279
KES 151.376059
KGS 102.610622
KHR 4703.906708
KMF 492.81343
KPW 1056.02802
KRW 1736.943149
KWD 0.360833
KYD 0.976807
KZT 606.561179
LAK 25385.542435
LBP 104960.335779
LKR 362.89366
LRD 207.457879
LSL 19.662411
LTL 3.464641
LVL 0.709756
LYD 6.353141
MAD 10.743823
MDL 19.843057
MGA 5330.313385
MKD 61.60011
MMK 2464.431858
MNT 4166.879392
MOP 9.394362
MRU 46.907758
MUR 54.17501
MVR 18.128533
MWK 2032.444691
MXN 21.122085
MYR 4.783227
MZN 74.995458
NAD 19.662747
NGN 1711.915715
NIO 43.136009
NOK 11.894511
NPR 168.034124
NZD 2.029398
OMR 0.45116
PAB 1.172073
PEN 3.947178
PGK 4.986162
PHP 68.993251
PKR 328.389238
PLN 4.205643
PYG 7863.363174
QAR 4.273149
RON 5.086416
RSD 117.383056
RUB 93.018839
RWF 1706.580996
SAR 4.401058
SBD 9.559106
SCR 16.336993
SDG 705.789525
SEK 10.866224
SGD 1.514473
SHP 0.880327
SLE 28.219844
SLL 24604.87134
SOS 668.652483
SRD 45.105889
STD 24286.276292
STN 24.520365
SVC 10.255474
SYP 12975.512305
SZL 19.659909
THB 36.586091
TJS 10.800924
TMT 4.106776
TND 3.430849
TOP 2.825181
TRY 50.228508
TTD 7.955573
TWD 36.975015
TZS 2914.028456
UAH 49.558404
UGX 4192.481957
USD 1.173365
UYU 46.018219
UZS 14090.462297
VES 331.076119
VND 30899.967624
VUV 141.511723
WST 3.271124
XAF 656.488242
XAG 0.017038
XAU 0.000266
XCD 3.171076
XCG 2.112445
XDR 0.816461
XOF 656.488242
XPF 119.331742
YER 279.730202
ZAR 19.609678
ZMK 10561.685231
ZMW 26.518459
ZWL 377.822893
  • NGG

    -0.0510

    76.04

    -0.07%

  • SCS

    0.0200

    16.14

    +0.12%

  • RYCEF

    0.2100

    15.61

    +1.35%

  • CMSD

    -0.0200

    23.22

    -0.09%

  • CMSC

    -0.1200

    23.17

    -0.52%

  • RIO

    1.5500

    79.87

    +1.94%

  • GSK

    0.2400

    48.85

    +0.49%

  • AZN

    -0.1500

    91.21

    -0.16%

  • RBGPF

    0.7800

    81

    +0.96%

  • BCE

    -0.1040

    22.741

    -0.46%

  • JRI

    0.0090

    13.39

    +0.07%

  • VOD

    0.0600

    12.9

    +0.47%

  • RELX

    0.1700

    40.92

    +0.42%

  • BTI

    0.6650

    57.09

    +1.16%

  • BP

    0.5100

    34.43

    +1.48%

  • BCC

    -0.0400

    74.72

    -0.05%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

N.Zaugg--NZN